Antihepatitis C virus therapy in liver transplanted patients

Hepatitis C virus (HCV) management in the transplant setting is still an open issue. The therapeutic strategies being addressed include: (a) pre-transplant prophylaxis (to prevent the infection of the transplanted organ); (b) post-transplant prophylaxis (to reduce the possibility of developing acute...

Descripción completa

Detalles Bibliográficos
Autor principal: Picciotto, Antonino
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661645/
https://www.ncbi.nlm.nih.gov/pubmed/18360580
_version_ 1782131057209901056
author Picciotto, Antonino
author_facet Picciotto, Antonino
author_sort Picciotto, Antonino
collection PubMed
description Hepatitis C virus (HCV) management in the transplant setting is still an open issue. The therapeutic strategies being addressed include: (a) pre-transplant prophylaxis (to prevent the infection of the transplanted organ); (b) post-transplant prophylaxis (to reduce the possibility of developing acute hepatitis); (c) management once the chronic disease has already set in and stabilized. Combination therapy with peginterferon alfa-2b plus ribavirin seems to play an important role for patients with established recurrent hepatitis C.
format Text
id pubmed-1661645
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-16616452008-03-21 Antihepatitis C virus therapy in liver transplanted patients Picciotto, Antonino Ther Clin Risk Manag Review Hepatitis C virus (HCV) management in the transplant setting is still an open issue. The therapeutic strategies being addressed include: (a) pre-transplant prophylaxis (to prevent the infection of the transplanted organ); (b) post-transplant prophylaxis (to reduce the possibility of developing acute hepatitis); (c) management once the chronic disease has already set in and stabilized. Combination therapy with peginterferon alfa-2b plus ribavirin seems to play an important role for patients with established recurrent hepatitis C. Dove Medical Press 2006-03 2006-03 /pmc/articles/PMC1661645/ /pubmed/18360580 Text en © 2006 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Picciotto, Antonino
Antihepatitis C virus therapy in liver transplanted patients
title Antihepatitis C virus therapy in liver transplanted patients
title_full Antihepatitis C virus therapy in liver transplanted patients
title_fullStr Antihepatitis C virus therapy in liver transplanted patients
title_full_unstemmed Antihepatitis C virus therapy in liver transplanted patients
title_short Antihepatitis C virus therapy in liver transplanted patients
title_sort antihepatitis c virus therapy in liver transplanted patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661645/
https://www.ncbi.nlm.nih.gov/pubmed/18360580
work_keys_str_mv AT picciottoantonino antihepatitiscvirustherapyinlivertransplantedpatients

Ejemplares similares